‹ ›
MYP_146203
Basic Information
Aducanumab
Immunology ▸ Immune modulation ▸ Immunomodulatory activity
not Standard
453 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
XVQLVESGGGVVQPGRSLRLSCAASGFAFSSYGMHWVRQAPGKGLEWVAVIWFDGTKKYYTDSVKGRFTISRDNSKNTLYLQMNTLRAEDTAVYYCARDRGIGARRGPYYMDVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG
Physicochemical Analysis
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available
Not available

Not available: incomplete physicochemical profile.

Molecular Weight
Not available
Isoelectric Point (pI)
Not available
Net Charge (pH 7.0)
Not available
GRAVY Index
Not available
Boman Index
Not available
Instability Index
Not available
The radar chart requires all six dimensions. Available values are listed above; missing values are not plotted as zero.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Readable PDBLast file check: 2026-11-18T17:08:04.666859+00:00. File readability does not guarantee 3D display.
Match index: Listed
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0118636 REVIEWED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Monoclonal antibody
9606
Structure & Mods
linear peptide/protein therapeutic [Linear]
noncanonical stereochemical or chemical modification [Modified]
Ambiguous/noncanonical residue symbol X present in deposited sequence
Bio-Activity Profile
Immunomodulatory Diagnostic
The terminal half life of aducanumab is 24.8 days.[L34393]
RECORD: Rec_0378200 REVIEWED: NO
Provenance & Taxonomy
Homo sapiens [Animal]
Monoclonal antibody
9606
Structure & Mods
linear peptide/protein therapeutic [Linear]
noncanonical stereochemical or chemical modification [Modified]
Ambiguous/noncanonical residue symbol X present in deposited sequence
Bio-Activity Profile
Diagnostic
The terminal half life of aducanumab is 24.8 days.[L34393]